|
|
Volumn 62, Issue 17, 2013, Pages 1636-
|
|
Mechanisms affecting platelet response to antiplatelet therapy in patients with ST-segment elevation myocardial infarction
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADENOSINE PHOSPHATE;
ANTITHROMBOCYTIC AGENT;
CYTOCHROME P450 3A;
MORPHINE;
PRASUGREL;
PURINERGIC P2Y12 RECEPTOR;
TICAGRELOR;
AGE;
BODY MASS;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR FUNCTION;
CARDIOVASCULAR INFLAMMATION;
CELLULAR IMMUNITY;
COMORBIDITY;
CORONARY ARTERY DISEASE;
CORONARY STENT;
CREATININE CLEARANCE;
CYP2C19 GENE;
DIABETES MELLITUS;
DNA POLYMORPHISM;
DRUG ABSORPTION;
DRUG INTERACTION;
DRUG UNDERDOSE;
ENVIRONMENTAL FACTOR;
FIBRINOGEN BLOOD LEVEL;
GENE;
GENETIC PREDISPOSITION;
GEOGRAPHIC ORIGIN;
HEART LEFT VENTRICLE EJECTION FRACTION;
HEREDITY;
HUMAN;
LETTER;
LOADING DRUG DOSE;
METABOLIC ACTIVATION;
OUTCOME ASSESSMENT;
PERCUTANEOUS CORONARY INTERVENTION;
PLATELET REACTIVITY;
PRIORITY JOURNAL;
RECEPTOR UPREGULATION;
SMOKING;
ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;
THROMBOCYTE;
THROMBOCYTE AGGREGATION INHIBITION;
THROMBOSIS;
TREATMENT REFUSAL;
ADENOSINE;
FEMALE;
HUMANS;
MYOCARDIAL INFARCTION;
PERCUTANEOUS CORONARY INTERVENTION;
PIPERAZINES;
PLATELET ACTIVATION;
PREOPERATIVE CARE;
THIOPHENES;
|
|
EID: 84886040995
PISSN: 07351097
EISSN: 15583597
Source Type: Journal
DOI: 10.1016/j.jacc.2013.05.082 Document Type: Letter |
|
Times cited : (3)
|
|
References (7)
|
